ArticleJournal of the American Heart Association2026
Association Between Copayments and Attendance in Cardiac Rehabilitation: A Nationwide Analysis From the AACVPR Registry.
Article in Journal of the American Heart Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association Between Initiation of Cardiac Rehabilitation after Hospitalization for Heart Failure and 1-Year Survival Among Medicare Beneficiaries.Journal of general internal medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundImproving cardiac rehabilitation (CR) participation is a national priority. This study examines the prevalence and cost of copays and their relationship with CR attendance and dropout.
methodsWe analyzed the AACVPR (American Association of Cardiovascular and Pulmonary Rehabilitation) registry using the AACVPR Data Analytic Center, including patients from 2012 to 2021 with recorded copayment (including 0) while excluding those without this data. The primary outcome was the association between total CR sessions attended and both copay presence and amount, assessed using multivariable models, adjusting for key literature-based adherence predictors and baseline patient characteristics.
resultsAmong 59 838 patients with copay data, 16 339 (27.3%) had a copay. The median (interquartile range) copay was $24.00 (20, 34). Medicare, Medicaid, private, and Other insurances charged a median (interquartile range) copay of $20.00 (20-25), $3.70 (3, 12), $30.00 (20-40), and $25.00 (20 to 36), respectively. Copays were more common in New York and the Northeast and less common in California and the Midwest. The highest copay amounts were observed in South Dakota, Oklahoma, and Connecticut (>$34.00). In multivariable model, the presence of copay was associated with attendance at 4.9 (95% CI: 4.3 to 5.6,
conclusionsCopays for CR were common, costly, and associated with fewer CR sessions. Policymakers should reconsider these policies to promote CR participation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.